| Literature DB >> 27355338 |
Rafael Ferreira1, Raphaella Coelho Michel1, Sebastião Luiz Aguiar Greghi1, Maria Lúcia Rubo de Resende1, Adriana Campos Passanezi Sant'Ana1, Carla Andreotti Damante1, Mariana Schutzer Ragghianti Zangrando1.
Abstract
The aim of this systematic literature review was to evaluate which type of periodontal preventive and therapeutic approaches presents superior outcomes in patients with Down syndrome (DS). Studies reporting different methods of periodontal care from DS patients were considered eligible. Included clinical studies should indicate at least two periodontal parameters in different periods of assessment. Screening of the articles, data extraction and quality assessment were conducted independently and in duplicate. Electronic search according to the PICO search, with both Key-words and MESH terms were conducted in MEDLINE, EMBASE and CENTRAL databases until March 2016. Manual search was conducted in four journals, namely Journal of Periodontology, Journal of Clinical Periodontology, Journal of Periodontal Research and Special Care in Dentistry and their electronic databases were searched. Electronic and manual search resulted in 763 papers, and of them 744 were excluded after title/abstract assessment. The full text of 19 potentially eligible publications was screened and 9 studies met inclusion criteria. The results demonstrated the importance to introduce youngest DS patients in preventive programs, as well as participation of parents, caregivers or institutional attendants in supervising/performing oral hygiene. In studies with higher frequency of attendance, all age groups presented superior preventive and therapeutic results, irrespective of the therapeutic approach used (surgical/nonsurgical/periodontal care program). The important factors for reducing periodontal parameters were the frequency of the appointments and association with chlorhexidine/plaque disclosing agents as adjuvant treatment. This systematic review demonstrated that early introduction in periodontal care, participation of parents/caregivers/institutional attendants, frequency of attendance and association with chemical adjuvants (independently of the periodontal treatment adopted) seems to improve periodontal outcomes in preventive and periodontal treatment of DS patients. Registration number (Prospero): CRD42016038433.Entities:
Mesh:
Year: 2016 PMID: 27355338 PMCID: PMC4927059 DOI: 10.1371/journal.pone.0158339
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Electronic search according to the PICO scheme, with both Key-words and MESH terms.
Characteristics of included studies about prevention.
| Autor (date) and country | Study design (follow up) | Sample size and gender (cases and controls) | Age of subjects (in years) or (mean ±standard deviation in years) | Procedures | Periodontal parameters (calibration) | Statistics | Main results | Quality assessment or risk of bias |
|---|---|---|---|---|---|---|---|---|
| Stabholz et al. 1991 [ | Longitudinal study (3 weeks) | Case: 30 institutionalized DS patients; Control: Absence | Case: 8–13; Control: absence | Group I (n = 10)- teeth coated with sustained-release delivery system of chlorhexidine (CHX); Group II (n = 10)- teeth coated with placebo solution; Group III (n = 10)- control (no intervention); Application twice a week for 21 days | PI [ | Kruskal-Wallis, ANOVA, Mann-Whitney | Group I- reduction of PI, GI and % bleeding; no statistical difference compared to Group II; Group I and II- reduction in clinical parameters with statistical difference compared to Group III | Medium quality |
| Shapira & Stabholz, 1996 [ | Longitudinal study (30 months) | Case: 20 DS institutionalized children (9 male/ 11 female); Control: absence | Case: 8–13; Control: absence | Elimination of dental biofilm (oral hygiene instruction, supra- and subgingival scaling), application of topical fluorides and fissure sealants. Periodontal maintenance treatment every four months (7 times) | PI [ | Wilcoxon | After 30 month-period, reduction of PI, GI and % bleeding, with statistical difference for PI and GI (p < 0.01) | Medium quality |
| Shyama et al, 2003 [ | Longitudinal study (3 months) | Case: 112 DS patients (67 females/ 45 males); Control: absence | Case: 11–22 (±14.8); Control: absence | School-based supervised tooth brushing program with dental health posters, classroom activities, videotapes, dental health slogans and supervised tooth brushing; No professional prophylaxis. | PI [ | Paired t-test, t test, ANOVA, Pearson’s correlation. | Significant reduction in PI and GI in all subjects (p<0.001). | Low quality |
| Teitelbaum et al, 2009 [ | Cross-over clinical trial | Case: 40 institutionalized DS patients; Control: absence | Case: 7–13;Control: Absence | Group I (fluoridated dentifrice); Group II (fluoridated dentifrice + CHX); Group III (fluoridated dentifrice + CHX + plaque-disclosing agent); Group IV (fluoridated dentifrice + plaque-disclosing agent); Experimental period 10 days, 15-day washout; Instructions on oral hygiene an orientation for parents and patients. | GI [ | Friedman test with Dunn post hoc test, Cochran test, Wilcoxon and McNemar | The comparison (intra-group) among the indices of initial and final PI and GI showed significant differences in all the groups (P < 0.001); PI reduction in all groups: Group I (15%) Group II (11%), Group III (64%) and Group IV (65%). Significant differences (p < 0.001) between Group III and Group IV for Group I and Group II; GI significant differences were observed among the groups (p < 0.001) with reduction the Group I (8%), Group II (21%), Group III (37%) and Group IV (18%). | Unclear risk of bias |
| Freedman et al, 2011 [ | Cross-over randomized trial (24 months) | Case: 27 DS patients, (15 females/ 12 males); Control: absence | Case: 9.2–43.1 (±25.4); Control: absence | Phase 1: 1% CHX varnish every 3-months+ 3 monthly prophylaxis+ 1% CHX gel at-home daily Phase 2: 40% CHX varnish every 6-months+ 6 monthly prophylaxis+ 1% CHX gel at-home daily Control phase: 6 monthly prophylaxis+ 1% CHX gel at-home daily.Experimental period 12 months, 3-month washout. Patients, parents and caregivers were instructed on oral hygiene and topical application of CHX. Evaluation with questionnaire. | Modified gingival index [ | Student’s t-test with matched pairs | There were significantly lower mean pocket probing depths and modified gingival indices for the control phase compared to phase one. There were significantly lower mean gingival bleeding indices for phase two compared to the control phase. | Unclear risk of bias |
DS, Down syndrome; BOP, bleeding on probing; CHX, chlorhexidine; CD, cerebral palsy; PD, probing depth; CAL, clinical attachment level; BL, bone loss; PI, plaque index; GI, gingival index; SRP, scaling and root planing
Characteristics of included studies about treatment.
| Author (date) and country | Study design (follow up) | Sample size and gender (cases and controls) | Age of Subjects (in years) or (mean ±standard deviation in years) | Procedures | Periodontal parameters (calibration) | Statistics | Main results | Quality Assessment or risk of bias |
|---|---|---|---|---|---|---|---|---|
| Cichon et al., 1998 [ | Controlled clinical trial (12 weeks) | Case: 10 DS patients (4 females/ 6 males); Control: 11 patients with cerebral palsy (CD) (4 females/ 7 males) | Case: 20–31; Control: 23–53 | Professional tooth cleaning and oral hygiene—instructions (only in Baseline) | PI [ | Wilcoxon signed-rank test | Clinical examinations 1, 4 and 12 weeks; Mean PI, GI scores; PD and CAL remained unchanged; Mean percentage (%) of sites with bleeding on probing (BOP) and with PD<3mm, 4-6mm, and >7mm during course of trial with no improvement | High risk of bias |
| Sakellari et al., 2001 [ | Longitudinal study (6 months) | Case: 5 DS patients (2 females/ 3 males); Control: absence | Case: 26–37; Control: absence | Professional tooth cleaning (twice SRP and every 6 weeks professional prophylaxis as 0.2% CHX mouthrinse solution to be used once daily) and oral hygiene instructions for patients and caregivers | PD; Probing attachment level (PAL); BOP; Hygiene index (presence or absence of plaque)—6 sites per tooth/full mouth; Calibration: present, but not related | Paired t-test | Reduction of PD, BOP and plaque after 3 months, with the exception of PAL; No difference in clinical parameters between the 3 and 6 months; Significant plaque reduction at 6 months, although 60% of sites were still positive for plaque | Medium quality |
| Zaldivar-Chiapa et al., 2005 [ | Split-mouth study—(1 year) | Case: 14 DS patients, (5 females/ 9 males) Control: absence | Case: 17–30—Control: absence | Surgical (open flap debridement) and non-surgical (SRP) periodontal therapies; Polishing weekly for 8 weeks, after that maintenance every 2 weeks for 4 months and once a month until completing 1 year | PI [ | Paired t test | Significant reduction in PI, GI and PD with both types of therapies (p<0.001); PDs of 1- 3mm were statistically significantly greater with non-surgical methods; Surgical treatment showed greater reduction in PDs for pockets >4mm | High risk of bias |
| Cheng et al., 2008 [ | Longitudinal case series (12 months) | 21 DS patients, (7 females/ 14 males) Control: absence | Case: 25.3±5.5; Control: absence | Oral hygiene instruction for DS patients and parents/guardians; Non-surgical mechanical periodontal therapy (SRP) followed by monthly recalls and the adjunctive use of CHX gel for brushing and CHX mouthwash twice daily | Presence of plaque; BOP; PD; CAL; 6 sites per tooth/full mouth; Calibration: absence | Deep pockets (≥7 mm): Plaque decreased from 99.1% to 38.4%; BOP 93.9% to 40.2%; mean PD decreased from 7.5 to 2.6 mm, with a mean gain in CAL of 2.9 mm; Moderately deep pockets (4 to 6 mm): Plaque decreased from 93.7% to 35.2%; BOP 93.1% to 37.9%; mean PD decreased from 4.5 to 2.2 mm, with a 1.1-mm gain in attachment level; Shallow sites (≤3 mm): Plaque decreased from 80.0% to 18.4%; BOP 76.2% to 26.7%; mean PD decreased from 2.4 to 1.6mm, with a 0.3-mm gain in attachment level | Medium quality |
DS, Down syndrome; BOP, bleeding on probing; CHX, chlorhexidine; CD, cerebral palsy; PD, probing depth; CAL, clinical attachment level; BL, bone loss; PI, plaque index; GI, gingival index; SRP, scaling and root planing
Fig 2Flowchart of manuscripts screened trough the review process.
Characteristics of preventive programs and periodontal therapies.
| Study/ Characteristics | Stabholz et al., 1991 [ | Shapira & Stabholz, 1996 [ | Cichon et al., 1998 [ | Sakellari et al., 2001 [ | Shyama et al., 2003 [ | Zaldivar-Chiapa et al., 2005 [ | Cheng et al., 2008 [ | Teitelbaum et al., 2009 [ | Freedman et al., 2011 [ |
|---|---|---|---|---|---|---|---|---|---|
| Intervention | Use of CHX/placebo/ control group | Professional care (supra- and subgingival scaling) | Professional care (supra- and subgingival scaling) | Professional care (supra- and subgingival scaling) | Supervised toothbrushing program | Surgical/ Non-surgical periodontal therapies | Professional care (scaling/root debridement) | Use of CHX dentifrice/ plaque disclosing agent | Use of CHX gel and CHX varnish |
| Parents/ Caregivers/ Institutional Attenders Participation | - | + | + | + | + | + | + | + | + |
| DS Patients Motivation | - | + | + | + | + | + | + | + | + |
| Frequency of Professional Attendance | 2x/week | four months | baseline | Each 6 weeks | 2x/week | 1x/week (2- month); 2x/month (4-month); 1x/month (until 1-year) | 1x/month | - | 3 and 6 months |
| Use of Adjunctive Chemical Agent | Sustained release delivery system CHX | - | - | 0.2% CHX mouthrinse (only in baseline) | - | 0.12% CHX mouthrinse (first 8 weeks) | 0.2% CHX mouthrinse/ 1%CHX gel (12 month) | CHX dentifrice/ plaque disclosing agent (3x/day) | 1% CHX gel/ 1% CHX varnish/ 40% CHX varnish |
| Periodontal Outcome Evaluation | + (CHX and placebo) | + (statistical difference) | - | + (until 3-month), no difference in 6-month evaluation | + (statistical difference), better outcomes in youngest subjects | +(statistical difference) for both therapies | + | +(plaque disclosing agent/CHX with statistical difference) | +(1% CHX gel) |
DS, Down syndrome; +, presence/positive; -, absence/negative